XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Cash Flows from Operating Activities        
Net loss $ (10,423,820) $ (2,662,311) $ (11,843,513) $ (1,467,887)
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation and amortization expense 318,923 96 478,191
Bad debt expense 12,000 23,500
Impairment expense     3,113,020
Equity based compensation expense 1,650,202 1,568,027 4,643,127 187,156
Recognized loss on marketable securities 18,740 101,417 160,449 101,208
Gain on sale of asset     (27,000)
Expenses paid through financings 32,500 15,000 15,000
Loan principal paid directly through grant (5,964)    
Amortization of debt discount and debt costs 214,885 32,522 39,372 1,944
Initial derivative expense 3,340,554    
Change in derivative value due to anti-dilution adjustments 2,642,175    
Change in fair value of derivative liability 904,176 (17,627) (1,138,604)
Changes in operating assets and liabilities:        
(Increase) decrease in accounts receivable 9,849 (420,916) (63,144) 43,388
(Increase) decrease in prepaid expenses and other current assets 269,051 (182,173) (73,620) (14,883)
Increase (decrease) in accounts payable and accrued liabilities (14,641) 991,807 3,259,458 389,142
Increase in other liabilities 49,554    
Increase (decrease) in deferred revenue (58,785) 9,959 22,906 4,758
Net cash used in operating activities (1,040,601) (564,199) (1,390,858) (755,174)
Cash Flows from Investing Activities        
Proceeds from sale of marketable securities 17,009 68,702 284
Proceeds from sale of asset     27,000
Cash paid for equipment (3,463) (3,463)
Cash paid for software development (11,500) (11,500) (72,770)
Net cash provided by (used in) investing activities 17,009 (14,963) 80,739 (72,486)
Cash Flows from Financing Activities        
Proceeds from notes 398,545 45,005 45,005 50,000
Proceeds from convertible notes, net of offering costs 2,226,000    
Payments of notes (7,396) (66,216) (105,034) (18,005)
Advances on receivables 180,778    
Repayments of advances on receivables (112,622)    
Repayments of liability on sale of future revenues (261,866)    
Proceeds from sale of future receivables     424,510
Repayments of receivables sale     (27,259)
Deposit on purchase of preferred stock 500,000 500,000
Repayment of deposit on purchase of preferred stock     (215,000)
Contributions to capital     65,000
Proceeds from sale of common stock     66,668
Proceeds from sale of preferred stock 25,000 979,997 979,997 300,000
Net cash provided by financing activities 2,448,439 1,458,786 1,602,219 463,663
Net increase in cash 1,424,847 879,624 292,100 (363,997)
Cash, beginning of period 306,252 14,152 14,152 378,149
Cash, end of period 1,731,099 893,776 306,252 14,152
Supplemental disclosures of cash flow information:        
Cash paid during the period for interest 86,438 24,245 49,552 53,416
Cash paid during the period for income taxes
Supplemental schedule of non-cash investing and financing activities:        
Original issue discount deducted from convertible note proceeds 328,125    
Debt costs deducted from convertible note proceeds 366,500    
Preferred stock issued for accrued penalties 1,929,516    
Preferred stock issued for asset acquisition 8,600,000 8,600,000
Subsidiary preferred shares converted to subsidiary common shares     154,000
Non-cash adjustments to Redeemable Preferred Stock of subsidiary 2,059,764 2,059,764 568,029
Notes payable and accrued interest exchanged for preferred stock 116,380 116,380
Noncontrolling interest reclassified to paid-in capital     1,591,221
Accounts payable paid through proceeds of preferred stock 100,000 100,000
Accrued compensation paid with common stock 56,250 56,250
Value of warrant issued with note 42,000 42,000
Accounts payable paid through proceeds of note 4,995 4,995
Warrant derivative liability at inception 5,625,519 1,750,646 1,750,646
Accrued compensation forgiven and credited to contributed capital 187,500 187,500
Discount attributable to Liability on Sale of Future Revenue     142,491  
Discount attributable to note payable     10,000  
Marketable securities received as payment for Series D preferred stock 240,000 240,000
Notes and accrued interest foregiven $ 706,502 $ 706,501